The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens

Microbes and Infection

Volumn 11, Issue 1, 2009, Pages 108-114

  Mayengue, Pembe Issamou ^a,b   Luty, Adrian J F ^c   Rogier, Christophe ^d   Baragatti, Meili ^d   Kremsner, Peter G ^a,b   Ntoumi, Francine ^a,b  

^a Hôpital Albert Schweitzer   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Tropical Med Inst for French Army   (France)

Author keywords

Antigens; Cytokines; Gabon; Immune responses; Multiplicity of infections; Plasmodium falciparum

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; FEMALE; FOLLOW UP; GENE; GENOTYPE; HUMAN; MALARIA FALCIPARUM; MALE; MSP 1 GENE; MSP 2 GENE; NONHUMAN; PARASITE IMMUNITY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BLOOD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GABON; HUMANS; IMMUNITY; INFANT; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PARASITEMIA; PLASMODIUM FALCIPARUM; YOUNG ADULT;

PLASMODIUM FALCIPARUM;

EID: 58249123684     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.10.012     Document Type: Article

References (30)

1. Ntoumi F., Contamin H., Rogier C., Bonnefoy S., Trape J.F., and Mercereau-Puijalon O. Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. Am. J. Trop. Med. Hyg. 52 (1995) 81-88
2. Ntoumi F., Mercereau-Puijalon O., Ossari S., et al. Plasmodium falciparum: sickle-cell trait is associated with higher prevalence of multiple infections in Gabonese children with asymptomatic infections. Exp. Parasitol. 87 (1997) 39-46
3. Arnot D. Unstable malaria in Sudan: the influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. Trans. R. Soc. Trop. Med. Hyg. 92 (1998) 580-585
4. al-Yaman F., Genton B., Reeder J.C., Anders R.F., Smith T., and Alpers M.P. Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 602-605
5. Farnert A., Rooth I., Svensson, Snounou G., and Bjorkman A. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. J. Infect. Dis. 179 (1999) 989-995
6. Beck H.P., Felger I., Vounatsou P., et al. Effect of iron supplementation and malaria prophylaxis in infants on Plasmodium falciparum genotypes and multiplicity of infection. Trans. R. Soc. Trop. Med. Hyg. 93 Suppl. 1 (1999) 41-45
7. Beck H.P., Felger I., Huber W., et al. Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66. J. Infect. Dis. 175 (1997) 921-926
8. Haywood M., Conway D.J., Weiss H., et al. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66. Trans. R. Soc. Trop. Med. Hyg. 93 Suppl. 1 (1999) 65-68
9. Engelbrecht F., Togel E., Beck H.P., Enwezor F., Oettli A., and Felger I. Analysis of Plasmodium falciparum infections in a village community in Northern Nigeria: determination of msp2 genotypes and parasite-specific IgG responses. Acta Trop. 74 (2000) 63-71
10. Bereczky S., Liljander A., Rooth I., et al. Multiclonal asymptomatic Plasmodium falciparum infections predict a reduced risk of malaria disease in a Tanzanian population. Microbes Infect. 9 (2007) 103-110
11. Kun J.F., Schmidt-Ott R.J., Lehman L.G., et al. Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Trans. R. Soc. Trop. Med. Hyg. 92 (1998) 110-114
12. Luty A.J., Ulbert S., Lell B., et al. Antibody responses to Plasmodium falciparum: evolution according to the severity of a prior clinical episode and association with subsequent reinfection. Am. J. Trop. Med. Hyg. 62 (2000) 566-572
13. Tebo A.E., Kremsner P.G., Piper K.P., and Luty A.J. Low antibody responses to variant surface antigens of Plasmodium falciparum are associated with severe malaria and increased susceptibility to malaria attacks in Gabonese children. Am. J. Trop. Med. Hyg. 67 (2002) 597-603
14. Yone C.L., Kremsner P.G., and Luty A.J. Immunoglobulin G isotype responses to erythrocyte surface-expressed variant antigens of Plasmodium falciparum predict protection from malaria in African children. Infect. Immun. 73 (2005) 2281-2287
15. Perkins D.J., Kremsner P.G., Schmid D., Misukonis M.A., Kelly M.A., and Weinberg J.B. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria. Infect. Immun. 67 (1999) 4977-4981
16. Luty A.J., Perkins D.J., Lell B., et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect. Immun. 68 (2000) 3909-3915
17. Sylla E.H., Kun J.F., and Kremsner P.G. Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon. Trans. R. Soc. Trop. Med. Hyg. 94 (2000) 652-656
18. Lell B., May J., Schmidt-Ott R.J., et al. The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin. Infect. Dis. 28 (1999) 794-799
19. Planche T., Krishna S., Kombila M., et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am. J. Trop. Med. Hyg. 65 (2001) 599-602
20. Ntoumi F., Ngoundou-Landji J., Lekoulou F., Luty A., Deloron P., and Ringwald P. Site-based study on polymorphism of Plasmodium falciparum MSP-1 and MSP-2 genes in isolates from two villages in Central Africa. Parassitologia 42 (2000) 197-203
21. Kun J.F., Mordmuller B., Perkins D.J., et al. Nitric oxide synthase 2 (Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J. Infect. Dis. 184 (2001) 330-336
22. Kun J.F., Klabunde J., Lell B., et al. Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene, Gabon. Am. J. Trop. Med. Hyg. 61 (1999) 776-779
23. Felger I., Smith T., Edoh D., et al. Multiple Plasmodium falciparum infections in Tanzanian infants. Trans. R. Soc. Trop. Med. Hyg. 93 Suppl. 1 (1999) 29-34
24. Ofosu-Okyere A., Mackinnon M.J., Sowa M.P., et al. Novel Plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season. Parasitology 123 (2001) 113-123
25. Basco L.K., and Ringwald P. Molecular epidemiology of malaria in Yaounde, Cameroon. VIII. Multiple Plasmodium falciparum infections in symptomatic patients. Am. J. Trop. Med. Hyg. 65 (2001) 798-803
26. Mockenhaupt F.P., Ehrhardt S., Otchwemah R., et al. Limited influence of haemoglobin variants on Plasmodium falciparum msp1 and msp2 alleles in symptomatic malaria. Trans. R. Soc. Trop. Med. Hyg. 98 (2004) 302-310
27. Ntoumi F., Ekala M.T., Makuwa M., Lekoulou F., Mercereau-Puijalon O., and Deloron P. Sickle cell trait carriage: imbalanced distribution of IgG subclass antibodies reactive to Plasmodium falciparum family-specific MSP2 peptides in serum samples from Gabonese children. Immunol. Lett. 84 (2002) 9-16
28. Mombo L.E., Ntoumi F., Bisseye C., et al. Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren. Am. J. Trop. Med. Hyg. 68 (2003) 186-190
29. Bull P.C., Lowe B.S., Kortok M., Molyneux C.S., Newbold C.I., and Marsh K. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med. 4 (1998) 358-360
30. Dodoo D., Omer F.M., Todd J., Akanmori B.D., Koram K.A., and Riley E.M. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J. Infect. Dis. 185 (2002) 971-979